Stoke Therapeutics
STOK
#4763
Rank
NZ$3.25 B
Marketcap
NZ$57.01
Share price
6.90%
Change (1 day)
141.91%
Change (1 year)

Earnings for Stoke Therapeutics (STOK)

Earnings in 2025 (TTM): NZ$75.81 Million

According to Stoke Therapeutics's latest financial reports the company's current earnings are NZ$0.20 Billion. In 2024 the company made an earning of -NZ$0.16 Billion, an increase over its 2023 earnings that were of -NZ$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Stoke Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$75.81 M-149.32%
2024 -NZ$0.16 Billion-15.01%
2023 -NZ$0.19 Billion3.59%
2022 -NZ$0.18 Billion17.79%
2021 -NZ$0.15 Billion64.24%
2020 -NZ$90.26 Million61.62%
2019 -NZ$55.85 Million158.17%
2018 -NZ$21.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion-464.89%๐Ÿ‡บ๐Ÿ‡ธ USA